Basic Information
LncRNA/CircRNA Name | MAGI2-AS3 |
Synonyms | NA |
Region | GRCh38_7:79452877-79471208 |
Ensemble | ENSG00000234456 |
Refseq | NR_038343 |
Classification Information
Regulatory Mechanism | Biological Function | Clinical Application | |||
---|---|---|---|---|---|
TF | Immune | Survival | |||
Enhancer | Apoptosis | Drug | |||
Variant | Cell Growth | Circulating | |||
MiRNA | EMT | Metastasis | |||
Methylation | Coding Ability | Recurrence |
Cancer&Entry Information
Cancer Name | cervical squamous cell carcinoma |
ICD-0-3 | C53 |
Methods | qPCR, Western blot |
Sample | CSCC tissues,C-33A human CSCC cell line |
Expression Pattern | up-regulated |
Function Description | CDK6 and MAGI2-AS3 were both up-regulated in CSCC and positively correlated with each other.High levels of MAGI2-AS3 were associated with the poor survival of CSCC patients. In CSCC cells, MAGI2-AS3 over-expression up-regulated CDK6, while MAGI2-AS3 siRNA down-regulated CDK6. In CCK-8 assay, MAGI2-AS3 and CDK6 over-expression led to increased proliferation rate of CSCC cells by reducing CDK6 levels. |
Pubmed ID | 31832086 |
Year | 2019 |
Title | LncRNA MAGI2-AS3 Is Involved in Cervical Squamous Cell Carcinoma Development Through CDK6 Up-Regulation |
External Links
Links for MAGI2-AS3 | GenBank HGNC NONCODE |
Links for cervical squamous cell carcinoma | OMIM COSMIC |